SCHEMBL7119755

SCHEMBL7119755

O=C(Nc1cccc(S(=O)(=O)N2CCCC2)c1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.69
ALDH1A1 P00352 5/20 0.69
HTT P42858 3/20 0.69
TSHR P16473 2/20 0.69
SIRT2 Q8IXJ6 1/20 0.68
KMT2A Q03164 7/20 0.67
MEN1 O00255 6/20 0.67
MAPT P10636 4/20 0.61
MAPK1 P28482 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
PKM P14618 1/20 0.61
NFKB1 P19838 1/20 0.61
CYP2C19 P33261 1/20 0.61
PPARG P37231 1/20 0.61
THPO P40225 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120981 0.89 MEN1 (0.82) LMNAALDH1A1HTTTSHRSIRT2
SCHEMBL7132443 0.89 MEN1 (0.81) LMNAALDH1A1HTTTSHRSIRT2
SCHEMBL29355583 0.81 SIRT2 (1.00) LMNAALDH1A1HTTSIRT2KMT2A
SCHEMBL13532186 0.81 SIRT2 (1.00) LMNAALDH1A1HTTSIRT2KMT2A
SCHEMBL1095860 0.81 SIRT2 (1.00) LMNAALDH1A1HTTSIRT2KMT2A
SCHEMBL7130551 0.81 RORC (0.82) LMNAHTTTSHRKMT2AMEN1
SCHEMBL1093544 0.81 ALDH1A1 (0.98) LMNAALDH1A1HTTTSHRKMT2A
SCHEMBL7129116 0.80 KMT2A (1.00) LMNATSHRKMT2AMEN1MAPT
SCHEMBL15612958 0.80 ALDH1A1 (0.77) LMNAALDH1A1HTTTSHRKMT2A
SCHEMBL7132438 0.79 RORC (0.71) LMNAHTTTSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD LMNA 3310/4885ALDH1A1 583/4885HTT 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.